News

Blog

NETRF Awards $3.5 Million in Grants

Research to Advance Neuroendocrine Tumor Treatment The Neuroendocrine Tumor Research Foundation (NETRF)  today announced $3.5 million in neuroendocrine tumor (NET) research grants to fund 12

Read More »
Blog

Spirituality and Cancer

Many people with neuroendocrine cancer look more deeply for meaning in their lives. They want to understand their purpose in life or why they got cancer.

Read More »
Blog

COMPETE Clinical Trial

A new phase III clinical trial called COMPETE (NCT03049189 ) compares everolimus, an oral targeted therapy, to PRRT with Lu-177 edotreotide, a radiopharmaceutical under development,

Read More »
Blog

A Look at Lung NETs

Approximately 20% of all primary lung tumors are neuroendocrine (Hung 2019), including: Typical carcinoid (TC) Atypical carcinoid (AC) Small cell carcinoma (SCC) Large cell carcinoma

Read More »